Home
>
National Drug Code (NDC)
>
Oxymorphone hydrochloride
Oxymorphone hydrochloride - 0115-1317-13 - (Oxymorphone hydrochloride)
Drug Information of Oxymorphone hydrochloride
| Product NDC: | 0115-1317 |
| Proprietary Name: | Oxymorphone hydrochloride |
| Non Proprietary Name: | Oxymorphone hydrochloride |
| Active Ingredient(s): | 30 mg/1 & nbsp; Oxymorphone hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Oxymorphone hydrochloride
| Product NDC: | 0115-1317 |
| Labeler Name: | Global Pharmaceuticals, Division of Impax Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA079087 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130102 |
Package Information of Oxymorphone hydrochloride
| Package NDC: | 0115-1317-13 |
| Package Description: | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1317-13) |
NDC Information of Oxymorphone hydrochloride
| NDC Code | 0115-1317-13 |
| Proprietary Name | Oxymorphone hydrochloride |
| Package Description | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1317-13) |
| Product NDC | 0115-1317 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Oxymorphone hydrochloride |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20130102 |
| Marketing Category Name | ANDA |
| Labeler Name | Global Pharmaceuticals, Division of Impax Laboratories, Inc. |
| Substance Name | OXYMORPHONE HYDROCHLORIDE |
| Strength Number | 30 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
